A detailed history of Nemes Rush Group LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Nemes Rush Group LLC holds 10,969 shares of EW stock, worth $729,109. This represents 0.14% of its overall portfolio holdings.

Number of Shares
10,969
Previous 9,318 17.72%
Holding current value
$729,109
Previous $890 Million 13.79%
% of portfolio
0.14%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$84.3 - $94.31 $139,179 - $155,705
1,651 Added 17.72%
10,969 $1.01 Billion
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $3.33 Million - $4.39 Million
-45,919 Reduced 83.13%
9,318 $890 Million
Q4 2023

Feb 09, 2024

BUY
$61.71 - $77.76 $184,821 - $232,891
2,995 Added 5.73%
55,237 $4.21 Billion
Q3 2023

Nov 09, 2023

BUY
$69.28 - $93.38 $297,973 - $401,627
4,301 Added 8.97%
52,242 $3.62 Billion
Q2 2023

Aug 02, 2023

BUY
$81.41 - $94.33 $3.9 Million - $4.52 Million
47,941 New
47,941 $4.52 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.